Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double‐Blind Study

Autor:	Henry R. Black, Fernando Aguirre Palacios, Mahendra Bijarnia, Andreas Kribben, Fabio Baschiera, Annik K. Laflamme
Jazyk:	angličtina
Rok vydání:	2010
Předmět:	Male medicine.medical_specialty Systolic hypertension Endocrinology Diabetes and Metabolism Medizin Blood Pressure Severity of Illness Index law.invention chemistry.chemical_compound Hydrochlorothiazide Randomized controlled trial Double-Blind Method Fumarates law Internal medicine Severity of illness Internal Medicine medicine Humans Antihypertensive Agents Aged Dose-Response Relationship Drug business.industry Aliskiren Middle Aged medicine.disease Amides Original Papers Confidence interval Dose–response relationship Endocrinology Blood pressure Treatment Outcome chemistry Hypertension Cardiology Drug Therapy Combination Female Cardiology and Cardiovascular Medicine business medicine.drug
Zdroj:	J Clin Hypertens (Greenwich)
Popis:	J Clin Hypertens (Greenwich). © 2010 Wiley Periodicals, Inc. Patients with stage 2 hypertension (systolic blood pressure [SBP] ≥160 mm Hg and/or diastolic blood pressure [DBP] ≥100 mm Hg) are at high cardiovascular risk and require intensive blood pressure (BP)–lowering therapy. This randomized double‐blind study is the first prospective trial specifically designed to evaluate the direct renin inhibitor aliskiren in patients with a mean sitting SBP ≥160 mm Hg and
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da72a5b859b1dd3c5d76e69ef6ac38b https://europepmc.org/articles/PMC8673334/ Zobrazit plný text záznamu